Mirion Technologies Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Tom Logan

Algemeen directeur

US$4.9m

Totale compensatie

Percentage CEO-salaris	15.1%
Dienstverband CEO	19.8yrs
Eigendom CEO	0.8%
Management gemiddelde ambtstermijn	2.6yrs
Gemiddelde ambtstermijn bestuur	3.1yrs

Recente managementupdates

Recent updates

What Mirion Technologies, Inc.'s (NYSE:MIR) 27% Share Price Gain Is Not Telling You

Oct 30

Is There An Opportunity With Mirion Technologies, Inc.'s (NYSE:MIR) 43% Undervaluation?

May 04

Mirion Technologies to benefit from $150M investment from T. Rowe Price

Feb 21

Mirion Technologies Non-GAAP EPS of $0.11 misses by $0.01, revenue of $217.9M beats by $17.11M, initiates 2023 outlook

Feb 14

Mirion Technologies, Inc. (NYSE:MIR) Shares Could Be 23% Below Their Intrinsic Value Estimate

Jan 07

Mirion Technologies: A Smart Way To Be Bullish On Clean Energy

Oct 05

A Look At The Intrinsic Value Of Mirion Technologies, Inc. (NYSE:MIR)

Sep 02

Mirion Technologies acquires CI business of Collins Aerospace

Aug 09

Mirion Technologies Non-GAAP EPS of $0.13 beats by $0.01, revenue of $175.8M misses by $5.32M

Jul 29

Mirion Technologies, Inc.'s (NYSE:MIR) Intrinsic Value Is Potentially 87% Above Its Share Price

May 12

Analyse CEO-vergoeding

Hoe is Tom Logan's beloning veranderd ten opzichte van Mirion Technologies's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$66m
Jun 30 2024	n/a	n/a	-US$65m
Mar 31 2024	n/a	n/a	-US$81m
Dec 31 2023	US$5m	US$738k	-US$97m
Sep 30 2023	n/a	n/a	-US$235m
Jun 30 2023	n/a	n/a	-US$270m
Mar 31 2023	n/a	n/a	-US$301m
Dec 31 2022	US$4m	US$700k	-US$277m
Sep 30 2022	n/a	n/a	-US$205m
Jun 30 2022	n/a	n/a	-US$204m
Mar 31 2022	n/a	n/a	-US$199m
Dec 31 2021	US$7m	US$326k	-US$222m

Compensatie versus markt: De totale vergoeding ($USD 4.88M ) Tom } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.50M ).

Compensatie versus inkomsten: De vergoeding van Tom is gestegen terwijl het bedrijf verliesgevend is.

CEO

Tom Logan (63 yo)

19.8yrs

Tenure

US$4,883,922

Compensatie

Mr. Thomas D. Logan, also known as Tom, serves Chief Executive Officer and Director of Mirion Technologies Inc. since 2005 and served as its Chairman and serves as Medical Group President since November 1,...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Thomas Logan	Founder	no data	US$4.88m	0.75% $ 25.8m
Brian Schopfer	Chief Financial Officer	4.5yrs	US$1.88m	0.10% $ 3.6m
Loic Eloy	Group President of Technologies	2.8yrs	US$842.32k	0.063% $ 2.2m
Christopher Moore	Chief Accounting Officer & Principal Accounting Officer	2.7yrs	geen gegevens	0.014% $ 466.2k
James Cocks	Chief Technology Officer	1.1yrs	geen gegevens	geen gegevens
Emmanuelle Lee	Chief Legal Officer	6.8yrs	geen gegevens	0.049% $ 1.7m
Erin Schesny	Chief Marketing Officer	1.1yrs	geen gegevens	geen gegevens
Alison Ulrich	Chief Human Resources Officer	2.6yrs	geen gegevens	0.015% $ 527.9k
Shelia Webb	Chief Digital Officer	1.8yrs	geen gegevens	geen gegevens
Mark Siviter	Chief Revenue Officer	less than a year	geen gegevens	geen gegevens

2.6yrs

Gemiddelde duur

49.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MIR wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Thomas Logan	Founder	19.8yrs	US$4.88m	0.75% $ 25.8m
Robert Cascella	Independent Director	3.1yrs	US$180.00k	0.014% $ 480.6k
John Kuo	Independent Director	3.1yrs	US$180.00k	0.028% $ 971.5k
Lawrence Kingsley	Chairman of the Board	3.1yrs	US$170.00k	2.29% $ 78.6m
Steven Etzel	Independent Director	no data	US$180.00k	0.028% $ 971.5k
Jody Markopoulos	Independent Director	3.1yrs	US$170.00k	0.022% $ 740.8k
Sheila Rege	Independent Director	2.2yrs	US$170.00k	0.0087% $ 299.3k
Kenneth Bockhorst	Lead Independent Director	3.1yrs	US$182.50k	0.028% $ 962.9k

3.1yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MIR wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).

Mirion Technologies Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Group President of Technologies recently sold US$219k worth of stock

High number of new directors

Mirion Technologies, Inc., Annual General Meeting, Jun 04, 2024

Chief Financial Officer notifies of intention to sell stock

Mirion Announces Resignation of Michael Rossi as Medical Group President, Effective November 1, 2023

Insufficient new directors

Recent updates

Price target increased by 11% to US$15.50

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

What Mirion Technologies, Inc.'s (NYSE:MIR) 27% Share Price Gain Is Not Telling You

Mirion Technologies, Inc. Revises Financial Guidance for the Fiscal Year Ending December 31, 2024

Mirion Technologies, Inc. to Report Q3, 2024 Results on Oct 29, 2024

Price target increased by 7.7% to US$14.00

Capital Allocation Trends At Mirion Technologies (NYSE:MIR) Aren't Ideal

Price target increased by 7.4% to US$13.25

What Mirion Technologies, Inc.'s (NYSE:MIR) P/S Is Not Telling You

New minor risk - Shareholder dilution

New minor risk - Insider selling

Group President of Technologies recently sold US$219k worth of stock

Mirion Technologies, Inc. Reiterates Revenue Guidance for the Full Year Period Ending December 31, 2024

Second quarter 2024 earnings released: US$0.058 loss per share (vs US$0.14 loss in 2Q 2023)

Is Mirion Technologies (NYSE:MIR) Using Too Much Debt?

Mirion Technologies, Inc. to Report Q2, 2024 Results on Aug 01, 2024

New minor risk - Shareholder dilution

Now 15% overvalued

Now 14% overvalued

Now 13% overvalued

New minor risk - Shareholder dilution

Now 21% overvalued

Revenues Not Telling The Story For Mirion Technologies, Inc. (NYSE:MIR)

New minor risk - Shareholder dilution

Now 20% overvalued after recent price rise

Is Mirion Technologies (NYSE:MIR) Using Too Much Debt?

First quarter 2024 earnings released: US$0.13 loss per share (vs US$0.22 loss in 1Q 2023)

Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024

High number of new directors

New minor risk - Shareholder dilution

Mirion Technologies, Inc., Annual General Meeting, Jun 04, 2024

Now 21% overvalued after recent price rise

Mirion Technologies, Inc. to Report Q1, 2024 Results on Apr 30, 2024

Is Mirion Technologies, Inc. (NYSE:MIR) Potentially Undervalued?

Chief Financial Officer notifies of intention to sell stock

Now 22% overvalued after recent price rise

Full year 2023 earnings released: US$0.49 loss per share (vs US$1.53 loss in FY 2022)

Getting In Cheap On Mirion Technologies, Inc. (NYSE:MIR) Is Unlikely

Price target increased by 16% to US$12.33

Full year 2023 earnings released: US$0.49 loss per share (vs US$1.53 loss in FY 2022)

Mirion Technologies, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024

Mirion Technologies, Inc. to Report Q4, 2023 Results on Feb 13, 2024

Calculating The Fair Value Of Mirion Technologies, Inc. (NYSE:MIR)

Mirion Technologies: A Good Way To Diversify Uranium Sector Exposure

Mirion Technologies, Inc. (NYSE:MIR) acquired Nuclear Medicine Information Systems, LLC for $33 million.

Third quarter 2023 earnings released: US$0.061 loss per share (vs US$0.26 loss in 3Q 2022)

Mirion Technologies, Inc. Reiterates Revenue Guidance for the Twelve Month Period Ending December 31, 2023

Mirion Announces Resignation of Michael Rossi as Medical Group President, Effective November 1, 2023

Mirion Technologies, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Mirion Technologies: Growing Steadily But Lacking Necessary Price Discount

Mirion Technologies: Wait When The Targets Are Met

New minor risk - Profitability

No longer forecast to breakeven

Mirion Technologies, Inc. Updates Its Revenue Guidance for the Fiscal Year Ending December 31, 2023

Second quarter 2023 earnings released: US$0.14 loss per share (vs US$0.32 loss in 2Q 2022)

New minor risk - Shareholder dilution

Mirion Technologies, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Mirion Technologies Introduces Genie™? 4.0 Spectroscopy Software, Now with Flexible Licensing Options

Mirion Technologies, Inc.'s (NYSE:MIR) Shareholders Might Be Looking For Exit

Mirion Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $53.55 million.

Mirion Technologies, Inc. Reaffirms Revenue Guidance for the Fiscal Year Ending December 31, 2023

Is There An Opportunity With Mirion Technologies, Inc.'s (NYSE:MIR) 43% Undervaluation?

First quarter 2023 earnings released: US$0.22 loss per share (vs US$0.098 loss in 1Q 2022)

Mirion Technologies to benefit from $150M investment from T. Rowe Price

Mirion Technologies, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023

Full year 2022 earnings released

Mirion Technologies Non-GAAP EPS of $0.11 misses by $0.01, revenue of $217.9M beats by $17.11M, initiates 2023 outlook

Mirion Technologies, Inc. to Report Q4, 2022 Results on Feb 14, 2023

Mirion Technologies, Inc. (NYSE:MIR) Shares Could Be 23% Below Their Intrinsic Value Estimate